Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative Colitis

Background. Adalimumab is effective for the maintenance of remission in patients with moderate-to-severe ulcerative colitis (UC). Currently, biologic therapies are used in cases where patients fail conventional medical therapies. If biologic therapies are not available, patients often choose to rema...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Can J Gastroenterol Hepatol
Main Authors: Beilman, Candace L., Thanh, Nguyen Xuan, Ung, Victoria, Ma, Christopher, Wong, Karen, Kroeker, Karen I., Lee, Thomas, Wang, Haili, Ohinmaa, Arto, Jacobs, Phil, Halloran, Brendan P., Fedorak, Richard N.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5065999/
https://ncbi.nlm.nih.gov/pubmed/27781203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/5315798
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados